Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$306,033
+$22,972 QoQ
Shares Held
1,205
+4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#4,148
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OGOREK ANTHONY JOSEPH /NY/ /ADV holds $11,041,030 across 10 Drug Manufacturers - General names. JNJ ranks #3 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,159 | $9,786,150 | |
| 2 | ABBV |
AbbVie Inc.
|
1,878 | $472,579 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,205 | $306,033 | |
| 4 | AMGN |
Amgen Inc
|
372 | $134,708 | |
| 5 | MRK |
Merck & Co., Inc.
|
980 | $125,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392 | $80,207 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
463 | $58,495 | |
| 8 | BIIB |
Biogen Inc.
|
152 | $32,841 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,033 | 1,205 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $283,061 | 1,158 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $250,823 | 1,212 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $248,833 | 1,342 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $193,228 | 1,265 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $241,960 | 1,459 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $101,812 | 704 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $113,279 | 699 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $101,435 | 694 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $108,992 | 689 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $107,680 | 687 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $103,729 | 666 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $114,539 | 692 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $102,610 | 662 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $83,202 | 471 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $76,615 | 469 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $83,074 | 468 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $82,766 | 467 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $79,547 | 465 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $74,936 | 464 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $76,274 | 463 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $75,765 | 461 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $72,394 | 460 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $38,559 | 259 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $43,173 | 307 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $40,125 | 306 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||